Impact of Sphincterotomy on Suprapapillary Inside Stent Patency in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Cohort Study
Endoscopy International Open · 28.09.2026 · 14 (CP)
DOI: 10.1055/a-2962-1556 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Endoscopy International Open, erschienen am 28.09.2026. Verfasst von So Nakaji und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of GastroenterologyKameda Medical CenterKamogawaChibaJapan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Study Aims The role of endoscopic sphincterotomy (EST) during suprapapillary inside stent placement for unresectable malignant hilar biliary obstruction (MHBO) remains uncertain. We evaluated its association with stent patency and adverse events. Patients and Methods This multicenter retrospective cohort included 376 consecutive patients treated at 8 institutions (2014–2024). The primary outcome was time to recurrent biliary obstruction (TRBO). Multivariable Cox regression, 1:1 propensity score matching (PSM), and competing-risk analysis were performed. Patients with prior EST were excluded from index-procedure safety analyses.
Results
Clinical success was achieved in 315 patients; 244 (77.5%) were in the EST group. TRBO did not differ between the EST and non-EST groups overall (median 170 vs 157 days; p = 0.85), after PSM (196 vs 207 days; p = 0.49), or in adjusted Cox analysis (hazard ratio 1.21, 95% CI 0.77–1.90). Competing-risk analysis likewise showed no difference (Gray’s p = 0.45). Among 360 patients without prior EST, PEP occurred in 7.8% versus 11.0% (p = 0.388), PEB in 1.5% versus 0% (p = 0.576), and perforation in 0.4% versus 0% (p = 1.000) in the index EST and non-EST groups, respectively. The single perforation was type III and was classified as mild in severity.
Conclusions
EST was not associated with longer initial stent patency. These retrospective findings do not support routine EST solely to prolong patency; its potential role in facilitating subsequent transpapillary reinterventions requires prospective evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of GastroenterologyKameda Medical CenterKamogawaChibaJapan.
- Saga Medical School Faculty of Medicine, Department of Metabolism and EndocrinologySaga UniversitySagaJapan.
- Department of MedicineKurume University School of MedicineKurumeJapan.
- Department of GastroenterologyChiba Cancer CenterChibaChiba PrefectureJapan.
- Department of GastroenterologySaga-ken Medical Center KoseikanSagaJapan.
- Department of GastroenterologyChiba UniversityChibaJapan.
ORCID-Profile: Yusuke Ishida, Hiroshi Ohyama
Zitieren
APA
Nakaji, S., Saito, K., Kita, E., Yoshioka, W., Kan, M., Ishida, Y., Mikata, R., Tanaka, K., Shiratori, T., Yoshimura, S., Ohyama, H., Tsuyuguchi, T., Yoshimura, S., Nakaya, Y., Tsuchiya, N., & Takahashi, H. (2026). Impact of Sphincterotomy on Suprapapillary Inside Stent Patency in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Cohort Study. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2962-1556
Vancouver
Nakaji S, Saito K, Kita E, Yoshioka W, Kan M, Ishida Y, et al. Impact of Sphincterotomy on Suprapapillary Inside Stent Patency in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Cohort Study. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2962-1556
BibTeX
@article{Nakaji2026,
author = {Nakaji, So and Saito, Kyoyoshi and Kita, Emiri and Yoshioka, Wataru and Kan, Motoyasu and Ishida, Yusuke and Mikata, Rintaro and Tanaka, Kenichi and Shiratori, Toshiyasu and Yoshimura, Sohei and Ohyama, Hiroshi and Tsuyuguchi, Toshio and Yoshimura, Shigenobu and Nakaya, Yoshiki and Tsuchiya, Naoaki and Takahashi, Hirokazu},
title = {Impact of Sphincterotomy on Suprapapillary Inside Stent Patency in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Cohort Study},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2962-1556}
}
EUVIMED